Tag: clinical trial economics

Using Real-World Data to Inform Diversity Policies & Incentives Decisions In the evolving landscape of clinical trials, the integration of real-world data (RWD) has become increasingly important in informing diversity policies and ensuring equitable participation. This tutorial aims to provide clinical operations, regulatory affairs, and medical affairs professionals with a step-by-step guide on leveraging RWD,…

Read More “Using Real-World Data to Inform Diversity Policies & Incentives Decisions” »

Governance Models and Cross-Functional Ownership for Diversity Policies & Incentives Governance Models and Cross-Functional Ownership for Diversity Policies & Incentives Introduction to Diversity in Clinical Trials Diversity in clinical trials is critical for ensuring that the findings are applicable across various populations. Traditionally, clinical trials have been criticized for their lack of diversity, which often…

Read More “Governance Models and Cross-Functional Ownership for Diversity Policies & Incentives” »

Diversity in Clinical Trials: A Fundamental Overview In the contemporary landscape of clinical trials, diversity is not merely an ethical or social consideration; it is a regulatory imperative. The emergence of various health disparities across different demographics underscores the necessity for clinical research organization companies to implement diversity policies and incentives. By fostering inclusivity within…

Read More “Diversity Policies & Incentives: What Clinical Leaders Need to Know Now” »

How to Model Diversity Policies & Incentives for Global Study Portfolios How to Model Diversity Policies & Incentives for Global Study Portfolios The need for diversity in clinical trials has gained unprecedented attention, prompted by recent movements within the healthcare and research communities. As regulatory agencies worldwide, including the FDA, EMA, and MHRA, emphasize inclusivity…

Read More “How to Model Diversity Policies & Incentives for Global Study Portfolios” »

Diversity Policies & Incentives in Practice: Benchmarks, Case Studies and Playbooks Diversity Policies & Incentives in Practice: Benchmarks, Case Studies and Playbooks Introduction: The Importance of Diversity in Clinical Trials Diversity in clinical trials is not merely a regulatory mandate; it is essential for the development of effective and safe therapeutics across varied populations. The…

Read More “Diversity Policies & Incentives in Practice: Benchmarks, Case Studies and Playbooks” »

High-Impact Diversity Policies & Incentives Strategies That Protect Trial Timelines and Margins High-Impact Diversity Policies & Incentives Strategies That Protect Trial Timelines and Margins In the rapidly evolving landscape of clinical trials, the implementation of diversity policies and incentives has emerged as a crucial strategy for biopharmaceutical companies. This article serves as a comprehensive guide…

Read More “High-Impact Diversity Policies & Incentives Strategies That Protect Trial Timelines and Margins” »

Linking Diversity Policies & Incentives to Market Access, HTA and Payer Expectations As the clinical research landscape continues to evolve, the integration of diversity policies and incentives has become crucial for ensuring market access and aligning with Health Technology Assessment (HTA) and payer expectations. This article provides a comprehensive step-by-step tutorial guide for clinical operations,…

Read More “Linking Diversity Policies & Incentives to Market Access, HTA and Payer Expectations” »